Doctor of Pharmacy Candidate
San Antonio, TX
Anticipated graduation: May 2020
GPA: 3.94
San Antonio, TX
Anticipated graduation: May 2020
GPA: 3.94
Houston, TX
Major: Nutrition, Minor: Health
GPA: 3.5
Texas City, TX
GPA: 3.79
San Antonio, TX
San Antonio, TX
San Antonio, TX
San Antonio, TX
San Antonio, TX
Houston, TX
League City, TX
"Bar Coding Medication Administration (BCMA) Quality Assurance Project"
"An Education Toolkit to Improve Awareness of Antimicrobial Resistance and Prescribing Practices for Lower Urinary Tract Infections in the Outpatient Setting"
Audience: Clinical pharmacist and pharmacy students
Audience: clinical pharmacist and nurses
Audience: clinical pharmacists, residents, and pharmacy students
Audience: pharmacy manager, clinical pharmacist and preceptor
Audience: pharmacy students, clinical pharmacist and residents
Audience: pharmacy students and pharmacist
Audience: pharmacy students and pharmacist
Audience: pharmacy students and professor
Bohula EA, Wiviott SD, McGuire DK, et al. Cardiovascular safety of lorcaserin in overweight or obese patients (CAMELLIA-TIMI 61). N Engl J Med. 2018;379(12):1107-1117. doi: 10.1056/NEJMoa1808721
PREDESCI. Villanueva C, Albillos A, Genesca J, et al. Beta Blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension. The Lancet. 2019 April 20; 393(10181):1597-1608
Carrier M, et al. “Apixaban to Prevent Venous Thromboembolism in Patients with Cancer”. The New England Journal of Medicine. 2018. E-pub 2018-12-04:1-8
The Hokusai-VTE Investigators. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med.2013;369(15):1406-1415
Cannon CP, Blazing MA, Guigliano RP, et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 2015;372(25):2387-97
Available upon request